Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 2004 May;59(5):434–437. doi: 10.1136/thx.2003.007542

Objective assessment of criteria for selection of donor lungs suitable for transplantation

A Fisher 1, S Donnelly 1, G Pritchard 1, J Dark 1, P Corris 1
PMCID: PMC1747005  PMID: 15115876

Abstract

Background: Donor organ shortage severely limits lung transplantation as a therapeutic option, yet many potential donor lungs are deemed unsuitable by clinical selection criteria.

Methods: Of 39 consecutive potential donor lungs, 14 were accepted and 25 excluded by clinical selection criteria. All were evaluated prospectively by clinical assessment, bronchoscopy, and bronchoalveolar lavage (BAL) to evaluate objectively the discrimination of pulmonary infection and injury.

Results: Accepted donors were significantly younger than those excluded (mean (SD) age 36.7 (15.3) years v 49.5 (13.2) years; p = 0.009, unpaired t test) and were more likely to have suffered traumatic brain death (50% v 20%; p = 0.07, Fisher's exact test). Oxygenation (PaO2:FiO2) was higher in accepted donors than in excluded donors (median (range) 63.2 (48–82.5) kPa v 43.1 (7.7–71.7) kPa; p = 0.0001, Mann-Whitney test). Positive formal BAL culture was more frequent in accepted donors (75%) than in those excluded (43%; p = 0.1, Fisher's exact test). There was no significant difference in the percentage and concentration of neutrophils in BAL fluid between accepted and excluded donors (median (range) 37.9 (0–96.9)% and 44.6 (0–1190)x103/ml v 36 (1–98.1)% and 46 (0.2–1457)x103/ml), nor in the BAL fluid concentration of tumour necrosis factor-α (140 (0–340) pg/ml v 160 (0–760) pg/ml) or interleukin 8 (810 (33–17 600) pg/ml v 540 (0–15 110) pg/ml).

Conclusion: Current selection criteria are poor discriminators of pulmonary injury and infection and lead to the exclusion of potentially usable donor lungs.

Full Text

The Full Text of this article is available as a PDF (194.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anyanwu A. C., Rogers C. A., Murday A. J., Steering Group Intrathoracic organ transplantation in the United Kingdom 1995-99: results from the UK cardiothoracic transplant audit. Heart. 2002 May;87(5):449–454. doi: 10.1136/heart.87.5.449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aziz Tarek M., El-Gamel Ahmed, Saad Rasheed A. G., Migliore Marcello, Campbell Colin S., Yonan Nizar A. Pulmonary vein gas analysis for assessing donor lung function. Ann Thorac Surg. 2002 May;73(5):1599–1605. doi: 10.1016/s0003-4975(02)03420-3. [DOI] [PubMed] [Google Scholar]
  3. Bhorade S. M., Vigneswaran W., McCabe M. A., Garrity E. R. Liberalization of donor criteria may expand the donor pool without adverse consequence in lung transplantation. J Heart Lung Transplant. 2000 Dec;19(12):1199–1204. doi: 10.1016/s1053-2498(00)00215-1. [DOI] [PubMed] [Google Scholar]
  4. Donnelly S. C., Strieter R. M., Kunkel S. L., Walz A., Robertson C. R., Carter D. C., Grant I. S., Pollok A. J., Haslett C. Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet. 1993 Mar 13;341(8846):643–647. doi: 10.1016/0140-6736(93)90416-e. [DOI] [PubMed] [Google Scholar]
  5. Fisher A. J., Dark J. H., Corris P. A. Improving donor lung evaluation: a new approach to increase organ supply for lung transplantation. Thorax. 1998 Oct;53(10):818–820. doi: 10.1136/thx.53.10.818. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fisher A. J., Donnelly S. C., Hirani N., Burdick M. D., Strieter R. M., Dark J. H., Corris P. A. Enhanced pulmonary inflammation in organ donors following fatal non-traumatic brain injury. Lancet. 1999 Apr 24;353(9162):1412–1413. doi: 10.1016/S0140-6736(99)00494-8. [DOI] [PubMed] [Google Scholar]
  7. Fisher A. J., Donnelly S. C., Hirani N., Haslett C., Strieter R. M., Dark J. H., Corris P. A. Elevated levels of interleukin-8 in donor lungs is associated with early graft failure after lung transplantation. Am J Respir Crit Care Med. 2001 Jan;163(1):259–265. doi: 10.1164/ajrccm.163.1.2005093. [DOI] [PubMed] [Google Scholar]
  8. Grover F. L., Fullerton D. A., Zamora M. R., Mills C., Ackerman B., Badesch D., Brown J. M., Campbell D. N., Chetham P., Dhaliwal A. The past, present, and future of lung transplantation. Am J Surg. 1997 Jun;173(6):523–533. doi: 10.1016/s0002-9610(97)00004-4. [DOI] [PubMed] [Google Scholar]
  9. Kron I. L., Tribble C. G., Kern J. A., Daniel T. M., Rose C. E., Truwit J. D., Blackbourne L. H., Bergin J. D. Successful transplantation of marginally acceptable thoracic organs. Ann Surg. 1993 May;217(5):518–524. doi: 10.1097/00000658-199305010-00012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Pierre Andrew F., Sekine Yasuo, Hutcheon Michael A., Waddell Thomas K., Keshavjee Shaf H. Marginal donor lungs: a reassessment. J Thorac Cardiovasc Surg. 2002 Mar;123(3):421-7; discussion, 427-8. doi: 10.1067/mtc.2002.120345. [DOI] [PubMed] [Google Scholar]
  11. Shumway S. J., Hertz M. I., Petty M. G., Bolman R. M., 3rd Liberalization of donor criteria in lung and heart-lung transplantation. Ann Thorac Surg. 1994 Jan;57(1):92–95. doi: 10.1016/0003-4975(94)90371-9. [DOI] [PubMed] [Google Scholar]
  12. Starnes V. A., Woo M. S., MacLaughlin E. F., Horn M. V., Wong P. C., Rowland J. M., Durst C. L., Wells W. J., Barr M. L. Comparison of outcomes between living donor and cadaveric lung transplantation in children. Ann Thorac Surg. 1999 Dec;68(6):2279–2284. doi: 10.1016/s0003-4975(99)01155-8. [DOI] [PubMed] [Google Scholar]
  13. Sundaresan S., Semenkovich J., Ochoa L., Richardson G., Trulock E. P., Cooper J. D., Patterson G. A. Successful outcome of lung transplantation is not compromised by the use of marginal donor lungs. J Thorac Cardiovasc Surg. 1995 Jun;109(6):1075–1080. doi: 10.1016/S0022-5223(95)70190-7. [DOI] [PubMed] [Google Scholar]
  14. Takada M., Nadeau K. C., Hancock W. W., Mackenzie H. S., Shaw G. D., Waaga A. M., Chandraker A., Sayegh M. H., Tilney N. L. Effects of explosive brain death on cytokine activation of peripheral organs in the rat. Transplantation. 1998 Jun 27;65(12):1533–1542. doi: 10.1097/00007890-199806270-00001. [DOI] [PubMed] [Google Scholar]
  15. Trulock E. P. Lung transplantation. Am J Respir Crit Care Med. 1997 Mar;155(3):789–818. doi: 10.1164/ajrccm.155.3.9117010. [DOI] [PubMed] [Google Scholar]
  16. Ware Lorraine B., Wang Yibing, Fang Xiaohui, Warnock Martha, Sakuma Tsutomu, Hall Timothy S., Matthay Michael. Assessment of lungs rejected for transplantation and implications for donor selection. Lancet. 2002 Aug 24;360(9333):619–620. doi: 10.1016/s0140-6736(02)09774-x. [DOI] [PubMed] [Google Scholar]
  17. Weill David, Dey Gerald C., Hicks R. Alan, Young K. Randall, Jr, Zorn George L., Jr, Kirklin James K., Early Lesley, McGiffin David C. A positive donor gram stain does not predict outcome following lung transplantation. J Heart Lung Transplant. 2002 May;21(5):555–558. doi: 10.1016/s1053-2498(01)00415-6. [DOI] [PubMed] [Google Scholar]
  18. Weill David. Donor criteria in lung transplantation: an issue revisited. Chest. 2002 Jun;121(6):2029–2031. doi: 10.1378/chest.121.6.2029. [DOI] [PubMed] [Google Scholar]
  19. Winton T. L. Lung transplantation: donor selection. Semin Thorac Cardiovasc Surg. 1992 Apr;4(2):79–82. [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES